Chiara Bernini
Overview
Explore the profile of Chiara Bernini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
122
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Horgan D, Metspalu A, Ouillade M, Athanasiou D, Pasi J, Adjali O, et al.
Biomed Hub
. 2021 May;
5(3):130-152.
PMID: 33987187
Recent advances in biomedicine are opening the door to new approaches, and treatment and prevention are being transformed by novel medicines based on genetic engineering, innovative cell-based therapies and tissue-engineered...
2.
Horgan D, Hackett J, Westphalen C, Kalra D, Richer E, Romao M, et al.
Biomed Hub
. 2021 Feb;
5(3):1341-1363.
PMID: 33564668
"A ship in the harbour is safe, but that is not what ships are built for," observed that sage 19th century philosopher William Shedd. In other words, technology of high...
3.
Horgan D, Ciliberto G, Conte P, Baldwin D, Seijo L, Montuenga L, et al.
Biomed Hub
. 2021 Feb;
5(3):182-223.
PMID: 33564664
Rapid and continuing advances in biomarker testing are not being matched by take-up in health systems, and this is hampering both patient care and innovation. It also risks costing health...
4.
Horgan D, Nobili F, Teunissen C, Grimmer T, Mitrecic D, Ris L, et al.
Biomed Hub
. 2021 Feb;
5(3):19-40.
PMID: 33564663
Alzheimer's disease (AD) and related dementia is one of the growing threats to the sustainability of health and care systems in developed countries, and efforts to find therapies have had...
5.
Horgan D, Ciliberto G, Conte P, Curigliano G, Seijo L, Montuenga L, et al.
Cancers (Basel)
. 2021 Feb;
13(3).
PMID: 33540773
Rapid and continuing advances in biomarker testing are not being matched by uptake in health systems, and this is hampering both patient care and innovation. It also risks costing health...
6.
Horgan D, Borisch B, Richer E, Bernini C, Kalra D, Lawler M, et al.
Biomed Hub
. 2020 Aug;
5(2):15-67.
PMID: 32775335
The scope and potential of personalised health care are underappreciated and underrealised, often because of resistance to change. The consequence is that many inadequacies of health care in Europe persist...
7.
Omar M, Roobol M, Ribal M, Abbott T, Agapow P, Araujo S, et al.
Nat Rev Urol
. 2020 Jun;
17(8):482.
PMID: 32587405
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
8.
Omar M, Roobol M, Ribal M, Abbott T, Agapow P, Araujo S, et al.
Nat Rev Urol
. 2020 May;
17(6):351-362.
PMID: 32461687
Prostate Cancer Diagnosis and Treatment Enhancement Through the Power of Big Data in Europe (PIONEER) is a European network of excellence for big data in prostate cancer, consisting of 32...
9.
Horgan D, Baker M, Riegman P, Bernini C
Biomed Hub
. 2020 Jan;
2(Suppl 1):16-21.
PMID: 31988925
Healthcare innovation has never been more prevalent than it is today. But these innovations are only very slowly being embedded into Europe's healthcare systems. There is a huge capacity here...
10.
Horgan D, Bernini C, Thomas P, Morre S
Public Health Genomics
. 2019 Oct;
22(3-4):77-101.
PMID: 31634895
Europe's growing awareness of gaps in its healthcare provision is not being matched by an increase in remedial action - despite the rich transformative potential of new approaches to data....